Related references
Note: Only part of the references are listed.Molecular Mechanisms Underlying IL-33-Mediated Inflammation in Inflammatory Bowel Disease
Ioanna Aggeletopoulou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD
Ariel A. Calderon et al.
EUROPEAN RESPIRATORY REVIEW (2023)
The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1+CD8+T cells in chronic viral infection
Anna-Friederike Marx et al.
IMMUNITY (2023)
Interleukin-33 Mediates Cardiomyopathy After Acute Kidney Injury by Signaling to Cardiomyocytes
Nans Florens et al.
CIRCULATION (2023)
Intestinal IL-33 promotes platelet activity or neutrophil recruitment during acute inflammation
Zuojia Chen et al.
BLOOD (2022)
Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target
Jie Jin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2022)
IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence
Hung-Yu Chiang et al.
NATURE COMMUNICATIONS (2022)
IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity
Corinne Cayrol
CELLS (2022)
IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues
Anissa A. Widjaja et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation
Maria Faas et al.
IMMUNITY (2021)
Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut
Mousumi Mahapatro et al.
CELLS (2021)
Myeloid-Derived IL-33 Limits the Severity of Dextran Sulfate Sodium-Induced Colitis
Li-Yin Hung et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity
Vittoria Palmieri et al.
MUCOSAL IMMUNOLOGY (2021)
Sprouty2 limits intestinal tuft and goblet cell numbers through GSK3β-mediated restriction of epithelial IL-33
Michael A. Schumacher et al.
NATURE COMMUNICATIONS (2021)
Transplantation of fecal microbiota from patients with inflammatory bowel disease and depression alters immune response and behavior in recipient mice
Hyo-Min Jang et al.
SCIENTIFIC REPORTS (2021)
IL-33/ST2 as a potential target for tumor immunotherapy
Wenyi Jiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases
Haocheng Zheng et al.
FRONTIERS IN IMMUNOLOGY (2021)
IL-33 in Rheumatic Diseases
Yuanji Dong et al.
FRONTIERS IN MEDICINE (2021)
IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers?
Moritz F. Eissmann et al.
FRONTIERS IN IMMUNOLOGY (2020)
IL-22-induced cell extrusion and IL-18-induced cell death prevent and cure rotavirus infection
Zhan Zhang et al.
SCIENCE IMMUNOLOGY (2020)
Interleukin (IL)-33 and the IL-1 Family of Cytokines-Regulators of Inflammation and Tissue Homeostasis
Ajithkumar Vasanthakumar et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2019)
Interleukin-18 in Health and Disease
Koubun Yasuda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
IL-33 at the Crossroads of Metabolic Disorders and Immunity
Lei Tu et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
ILC3 function as a double-edged sword in inflammatory bowel diseases
Boning Zeng et al.
CELL DEATH & DISEASE (2019)
The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
Eva Pastille et al.
MUCOSAL IMMUNOLOGY (2019)
IL-33 and IL-18 in Inflammatory Bowel Disease Etiology and Microbial Interactions
Michelle A. Williams et al.
FRONTIERS IN IMMUNOLOGY (2019)
IL-33 Induces Murine Intestinal Goblet Cell Differentiation Indirectly via Innate Lymphoid Cell IL-13 Secretion
Amanda Waddell et al.
JOURNAL OF IMMUNOLOGY (2019)
IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
Ben C. L. Chan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Interleukin-33 Promotes REG3γ Expression in Intestinal Epithelial Cells and Regulates Gut Microbiota
Yi Xiao et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
IL22 Inhibits Epithelial Stem Cell Expansion in an Ileal Organoid Model
Bailey Zwarycz et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
New biologics and small molecules in inflammatory bowel disease: an update
Joao Sabin et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
Corinne Cayrol et al.
IMMUNOLOGICAL REVIEWS (2018)
IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow
Matthew T. Stier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Clinical importance of IL-22 cascade in IBD
Atsushi Mizoguchi et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Dichotomous function of IL-33 in health and disease: From biology to clinical implications
Harald Braun et al.
BIOCHEMICAL PHARMACOLOGY (2018)
IL-33/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation
Kelei Cao et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases
Wei-Yu Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation
Katrin Neumann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
Loris R. Lopetuso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
IL-33/ST2 Axis in Organ Fibrosis
Ourania S. Kotsiou et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine
Jean-Jacques Fournie et al.
FRONTIERS IN IMMUNOLOGY (2018)
Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
Donye Dominguez et al.
JOURNAL OF IMMUNOLOGY (2017)
Mast Cells Are Crucial for Induction of Group 2 Innate Lymphoid Cells and Clearance of Helminth Infections
Chikako Shimokawa et al.
IMMUNITY (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
NLRP6 Protects II10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila
Sergey S. Seregin et al.
CELL REPORTS (2017)
The ST2/IL-33 Axis in immune Cells during inflammatory Diseases
Brad Griesenauer et al.
FRONTIERS IN IMMUNOLOGY (2017)
Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease
Dong Hyuk Seo et al.
SCIENTIFIC REPORTS (2017)
Understanding Interleukin 33 and Its Roles in Eosinophil Development
Laura K. Johnston et al.
FRONTIERS IN MEDICINE (2017)
IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment
Min Fang et al.
CANCER RESEARCH (2017)
Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer
Christian Schwartz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
IL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesis
Ankit Malik et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Christoph S. N. Klose et al.
NATURE IMMUNOLOGY (2016)
Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity
Katherine Gil-Cardoso et al.
NUTRITION RESEARCH REVIEWS (2016)
Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection
Mousumi Mahapatro et al.
CELL REPORTS (2016)
Interleukin-33 in health and disease
Foo Yew Liew et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
Roni Nowarski et al.
CELL (2015)
Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions
Dario G. Lupianez et al.
CELL (2015)
The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation
Mario M. Zaiss et al.
IMMUNITY (2015)
Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
Ari B. Molofsky et al.
IMMUNITY (2015)
IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function
Amanda Waddell et al.
INFLAMMATORY BOWEL DISEASES (2015)
IL-33 alleviates DSS-induced chronic colitis in C57BL/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response
Junfeng Zhu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
Caroline A. Lindemans et al.
NATURE (2015)
Control of adaptive immunity by the innate immune system
Akiko Iwasaki et al.
NATURE IMMUNOLOGY (2015)
IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions
Laurel A. Monticelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mo1779 Interleukin-33 Induces Distinct Gastric Epithelial Alterations and Plays an Important Role in the Pathogenesis of Murine Gastritis
Luca Pastorelli et al.
GASTROENTEROLOGY (2015)
IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis
Jakob Benedict Seidelin et al.
JOURNAL OF GASTROENTEROLOGY (2015)
REG3γ-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum
L. M. P. Loonen et al.
MUCOSAL IMMUNOLOGY (2014)
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Chris Schiering et al.
NATURE (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
Lance W. Peterson et al.
NATURE REVIEWS IMMUNOLOGY (2014)
IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent
Zhonghan Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
Mamdouh A. K. Sedhom et al.
GUT (2013)
The Role of IL-33 in Gut Mucosal Inflammation
Luca Pastorelli et al.
MEDIATORS OF INFLAMMATION (2013)
Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
Anna Latiano et al.
PLOS ONE (2013)
Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies
Hongnga Le et al.
FRONTIERS IN IMMUNOLOGY (2013)
Central role of the gut epithelial barrier in the pathogenes of chronic intestinal inflammation: lessons learned from animal models and human genetics
Luca Pastorelli et al.
FRONTIERS IN IMMUNOLOGY (2013)
Role of the gut microbiota in immunity and inflammatory disease
Nobuhiko Kamada et al.
NATURE REVIEWS IMMUNOLOGY (2013)
IL-33/ST2 axis in inflammation and immunopathology
Marija Milovanovic et al.
IMMUNOLOGIC RESEARCH (2012)
Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/Foxp3+ Regulatory T-Cell Responses in Mice
Lihua Duan et al.
MOLECULAR MEDICINE (2012)
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis
Loris R. Lopetuso et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine
Sarah L. Kempster et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Eran Elinav et al.
CELL (2011)
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
Ivan Jovanovic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Expression and Effects of IL-33 and ST2 in Allergic Bronchial Asthma: IL-33 Induces Eotaxin Production in Lung Fibroblasts
Masatsugu Kurokawa et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2011)
Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161
Jenny M. Mjosberg et al.
NATURE IMMUNOLOGY (2011)
A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease
Eleonora A. M. Festen et al.
PLOS GENETICS (2011)
Gut microbiota, immunity, and disease: a complex relationship
Michele M. Kosiewicz et al.
FRONTIERS IN MICROBIOLOGY (2011)
IL-33 is upregulated in colonocytes of ulcerative colitis
Jakob Benedict Seidelin et al.
IMMUNOLOGY LETTERS (2010)
Characterization of the Novel ST2/IL-33 System in Patients with Inflammatory Bowel Disease
Carol J. Beltran et al.
INFLAMMATORY BOWEL DISEASES (2010)
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
Ayako Kobori et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Daniel R. Neill et al.
NATURE (2010)
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
Jose C. Alves-Filho et al.
NATURE MEDICINE (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Disease-associated functions of IL-33: the new kid in the IL-1 family
Foo Y. Liew et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Inhibition of Interleukin-33 Signaling Attenuates the Severity of Experimental Arthritis
Gaby Palmer et al.
ARTHRITIS AND RHEUMATISM (2009)
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
S. Brand
GUT (2009)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
Microbial influences in inflammatory bowel diseases
R. Balfour Sartor
GASTROENTEROLOGY (2008)
Strategies for use of IL-10 or its antagonists in human disease
Anne O'Garra et al.
IMMUNOLOGICAL REVIEWS (2008)
IL-33, a potent inducer of adaptive immunity to intestinal nematodes
Neil E. Humphreys et al.
JOURNAL OF IMMUNOLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease
Steven A. McCarroll et al.
NATURE GENETICS (2008)
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Rahul Kakkar et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
David Artis
NATURE REVIEWS IMMUNOLOGY (2008)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model
H Ogawa et al.
INFLAMMATORY BOWEL DISEASES (2003)
Share Paper
